"Personalised medicine is one of the key drivers in the pharma industry, but I must admit that I am concerned about the sustainability of the current…
In Conversation
"The key to success in the Colombian market is access. Some of our products, such as diabetes related treatments, are included in the public health national…
"Brazil is the sixth largest pharmaceutical market in the world and we are steadily moving toward the fifth position, which we will probably reach within the…
"There are around 30 companies doing genetic testing in Europe and thankfully we supply 75 percent of the market. In fact, Novogenia is one of the…
"We are selective when it comes to our internationalisation strategy. Our priority is to make sure the products have a good regulatory fit with the country."
"A key challenge we have – at Gilead but also as an industry – is how to expedite access to medicines for patients in Canada."
"Bulgarian patients’ access to innovative medicines has drastically improved over the last decade"
"We believe having an approach based around long-term stability allows our customers to trust and rely on Théa, and this will continue well into the future."
Felipe Jaramillo, president at ProColombia, the government agency in charge of strengthening the country’s image, describes how Colombia successfully transitioned from being a war-damaged country to…
"First and foremost, we are looking to establish a free trade agreement with the US."
"We believe collaboration with institutions serves as fundamental to building a strong presence in [Colombia]"
"Even at a local level we have built on a strong relationship with our diversifying partners, and this has heavily contributed to our patient-centric approach."
